This training program is geared toward trainees who aim to pursue integrated, translational research that is focused on advancing promising new nanotechnology-based diagnostics and therapeutics to improve cancer care.
How to Apply
Interested candidates should send via email their applications as a single pdf file with “2018 T32 Cancer Nanotechnology Postdoctoral Application” denoted in the subject line.
Application packages are due by May 31, 2018 at midnight, Central Time and should include:
I. Personal information – name, postal address, email address, phone number, citizenship, graduate school name, location, and your GPA. Also specify if you are applying for a postdoctoral or predoctoral position.
II. Cover letter describing specific research interests and your preferred co-mentors (no more than one page)
IV. Names of three references
V. For predoctoral candidates only, submit your Rice graduate transcript, too.
About the Program
The goal of this program is to train scientists who will transfer the great promise of nanotechnology into clinical reality. This novel training program educates future leaders in the broad field of nanotechnology with specific interests in cancer-related applications, who are keenly aware of the needs and demands of clinical environment as well as of major challenges of translational research.
Our Program Has Two Tiers
Predoctoral Program - provides mentorship, training, and funding for two years to students who have been accepted into the Ph.D. program in Bioengineering, Chemistry, or Applied Physics at Rice University and have completed one or two years of their didactic coursework.
Postdoctoral Program - provides a two-year fellowship to recent Ph.D. awardees with training in physical science, chemistry, or bioengineering with a demonstrated background and interest in nanotechnology.
Holders of an M.D. degree will be eligible for the program if they show a strong interest in translational cancer nanotechnology research.
This training program includes multidisciplinary, hands-on coursework, seminar experiences, and multidisciplinary mentorship of translational research projects.
Shared laboratory facilities and equipment provide program fellows with an outstanding research environment that combines state-of-the-art instrumentation, facilities for animal research, and vast opportunities to be an integral part of clinical trials.
The program includes a total of 25 faculty mentors (18) and co-mentors (seven) from MD Anderson Cancer Center (eight mentors and six co-mentors) and Rice University (10 mentors and one co-mentor).
Per program requirements, fellows “must be a citizen or a noncitizen national of the United States or have been lawfully admitted for permanent residence at the time of appointment.” Noncitizen national of the United States applies to those born or with ties to the outlying U.S. possessions of American Samoa and Swains Island.
MD Anderson Applications
Manager, Clinical Protocol Administration
Department of Imaging Physics